Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...

A federal judge denied Teva's bid to delay the first Paragard bellwether trial, keeping a January start date for claims tied to IUD breakage injuries.

Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...

Newly issued patent covers a new medical device and method to deliver and remove hydrogel within the body, including Plan A™’s sperm occlusion system. We have been thoughtfully innovating for several ...

The T-shaped intrauterine device releases levonorgestrel, a hormone that stops the womb lining from thickening and consequently prevents pregnancy. Women using Kyleena may also experience fewer days ...

(Reuters) - The U.S. Food and Drug Administration approved Bayer AG's hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the German company said on Monday. The small, ...

(Reuters) - The U.S. Food and Drug Administration approved a hormonal contraceptive device on Friday that gives American women another reversible contraceptive choice as effective as sterilization.

A patient was left with PTSD, depression and felt demoralised and demeaned after they got pregnant and had an abortion when a doctor failed to re-insert their contraceptive device. In 2021, Jessie ...